- Home
- STRO vs PEBK Comparison
STRO vs PEBK Comparison
Compare STRO & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- PEBK
- Stock Information
- Founded
- STRO 2003
- PEBK 1912
- Country
- STRO United States
- PEBK United States
- Employees
- STRO N/A
- PEBK N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- PEBK Major Banks
- Sector
- STRO Health Care
- PEBK Finance
- Exchange
- STRO Nasdaq
- PEBK Nasdaq
- Market Cap
- STRO 147.6M
- PEBK 169.6M
- IPO Year
- STRO 2018
- PEBK N/A
- Fundamental
- Price
- STRO $1.77
- PEBK $27.36
- Analyst Decision
- STRO Strong Buy
- PEBK
- Analyst Count
- STRO 7
- PEBK 0
- Target Price
- STRO $12.14
- PEBK N/A
- AVG Volume (30 Days)
- STRO 950.7K
- PEBK 7.3K
- Earning Date
- STRO 03-24-2025
- PEBK 02-12-2025
- Dividend Yield
- STRO N/A
- PEBK 2.34%
- EPS Growth
- STRO N/A
- PEBK 7.58
- EPS
- STRO N/A
- PEBK 2.98
- Revenue
- STRO $160,955,000.00
- PEBK $82,079,000.00
- Revenue This Year
- STRO N/A
- PEBK N/A
- Revenue Next Year
- STRO N/A
- PEBK N/A
- P/E Ratio
- STRO N/A
- PEBK $9.18
- Revenue Growth
- STRO 230.90
- PEBK 7.90
- 52 Week Low
- STRO $1.51
- PEBK $23.74
- 52 Week High
- STRO $6.13
- PEBK $33.31
- Technical
- Relative Strength Index (RSI)
- STRO 42.89
- PEBK 35.31
- Support Level
- STRO $1.76
- PEBK $29.66
- Resistance Level
- STRO $1.95
- PEBK $30.67
- Average True Range (ATR)
- STRO 0.13
- PEBK 0.77
- MACD
- STRO 0.00
- PEBK -0.17
- Stochastic Oscillator
- STRO 41.94
- PEBK 3.22
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh, and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.